BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thomsen HS, Morcos SK, Almén T, Bellin MF, Bertolotto M, Bongartz G, Clement O, Leander P, Heinz-Peer G, Reimer P. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2013;23:307-318. [PMID: 22865271 DOI: 10.1007/s00330-012-2597-9] [Cited by in Crossref: 305] [Cited by in F6Publishing: 235] [Article Influence: 30.5] [Reference Citation Analysis]
Number Citing Articles
1 Harrell AD, Johnson D, Samet J, Omar IM, Deshmukh S. With or without? A retrospective analysis of intravenous contrast utility in magnetic resonance neurography. Skeletal Radiol 2020;49:577-84. [DOI: 10.1007/s00256-019-03321-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Chacon-Caldera J, Maunder A, Rao M, Norquay G, Rodgers OI, Clemence M, Puddu C, Schad LR, Wild JM. Dissolved hyperpolarized xenon-129 MRI in human kidneys. Magn Reson Med 2020;83:262-70. [PMID: 31400040 DOI: 10.1002/mrm.27923] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
3 Huang R, Boltze J, Li S. Strategies for Improved Intra-arterial Treatments Targeting Brain Tumors: a Systematic Review. Front Oncol 2020;10:1443. [PMID: 32983974 DOI: 10.3389/fonc.2020.01443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Scala M, Koob M, de Buttet S, Bourrinet P, Felices M, Jurkiewicz E. A Pharmacokinetics, Efficacy, and Safety Study of Gadoterate Meglumine in Pediatric Subjects Aged Younger Than 2 Years. Invest Radiol 2018;53:70-9. [PMID: 28906338 DOI: 10.1097/RLI.0000000000000412] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Doniselli FM, Albano D, Chianca V, Cimmino MA, Sconfienza LM. Gadolinium accumulation after contrast-enhanced magnetic resonance imaging: what rheumatologists should know. Clin Rheumatol 2017;36:977-80. [PMID: 28321569 DOI: 10.1007/s10067-017-3604-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
6 Lattanzio SM; Department of Biomedical Sciences, University of Padua, Padua, Italy. . AIMS Biophysics 2021;8:198-220. [DOI: 10.3934/biophy.2021015] [Reference Citation Analysis]
7 Fretellier N, Granottier A, Rasschaert M, Grindel AL, Baudimont F, Robert P, Idée JM, Corot C. Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats. Invest Radiol 2019;54:61-71. [PMID: 30394964 DOI: 10.1097/RLI.0000000000000517] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
8 Bruce R, Wentland AL, Haemel AK, Garrett RW, Sadowski DR, Djamali A, Sadowski EA. Incidence of Nephrogenic Systemic Fibrosis Using Gadobenate Dimeglumine in 1423 Patients With Renal Insufficiency Compared With Gadodiamide. Invest Radiol. 2016;51:701-705. [PMID: 26885631 DOI: 10.1097/rli.0000000000000259] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 6.8] [Reference Citation Analysis]
9 Chang DH, Pracros JP. Safety of gadoterate meglumine in over 1600 children included in the prospective observational SECURE study. Acta Radiol 2019;60:1450-6. [PMID: 31027425 DOI: 10.1177/0284185119840649] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
10 Thomsen HS. Gadolinium- or iodine-based contrast media: which choice? Acta Radiol 2014;55:771-5. [DOI: 10.1177/0284185114533537] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 McWilliams RG, Frabizzio JV, De Backer AI, Grinberg A, Maes BD, Zobel BB, Gottschalk A. Observational study on the incidence of nephrogenic systemic fibrosis in patients with renal impairment following gadoterate meglumine administration: the NSsaFe study. J Magn Reson Imaging 2020;51:607-14. [PMID: 31287213 DOI: 10.1002/jmri.26851] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Lo CP, Kao HW, Chen SY, Chu CM, Hsu CC, Chen YC, Lin WC, Liu DW, Hsu WL. Comparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis. BMC Neurol 2014;14:100. [PMID: 24885357 DOI: 10.1186/1471-2377-14-100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
13 Laurent G, Bernhard C, Dufort S, Jiménez Sánchez G, Bazzi R, Boschetti F, Moreau M, Vu TH, Collin B, Oudot A, Herath N, Requardt H, Laurent S, Vander Elst L, Muller R, Dutreix M, Meyer M, Brunotte F, Perriat P, Lux F, Tillement O, Le Duc G, Denat F, Roux S. Minor changes in the macrocyclic ligands but major consequences on the efficiency of gold nanoparticles designed for radiosensitization. Nanoscale 2016;8:12054-65. [DOI: 10.1039/c6nr01228k] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Montagne A, Nation DA, Pa J, Sweeney MD, Toga AW, Zlokovic BV. Brain imaging of neurovascular dysfunction in Alzheimer's disease. Acta Neuropathol 2016;131:687-707. [PMID: 27038189 DOI: 10.1007/s00401-016-1570-0] [Cited by in Crossref: 107] [Cited by in F6Publishing: 101] [Article Influence: 17.8] [Reference Citation Analysis]
15 Benzon HT, Maus TP, Kang HR, Provenzano DA, Bhatia A, Diehn F, Nelson A, McCormick ZL, Liu BP, de Andres Ares J, Anitescu M, Blackham K, Bhaskar A, Brill S, Collins J, Gulve A, Hurley RW, Jeon YH, Moon JY, Rauck RL, Rodes M, Lee RK, Shah V, Shanthanna H, van Zundert J, Huntoon M, Rathmell JP, Borges MS, Cohen SP, Greenberger PA. The Use of Contrast Agents in Interventional Pain Procedures: A Multispecialty and Multisociety Practice Advisory on Nephrogenic Systemic Fibrosis, Gadolinium Deposition in the Brain, Encephalopathy After Unintentional Intrathecal Gadolinium Injection, and Hypersensitivity Reactions. Anesth Analg 2021;133:535-52. [PMID: 33755647 DOI: 10.1213/ANE.0000000000005443] [Reference Citation Analysis]
16 Faletti R, Cassinis MC, Gatti M, Giglio J, Guarnaccia C, Messina M, Bergamasco L, Fonio P. Acute pyelonephritis in transplanted kidneys: can diffusion-weighted magnetic resonance imaging be useful for diagnosis and follow-up? Abdom Radiol 2016;41:531-7. [DOI: 10.1007/s00261-015-0618-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
17 Lachance A, Abu-alfa AK, Cowper SE. Nephrogenic Systemic Fibrosis. In: Nunley JR, Lerma EV, editors. Dermatological Manifestations of Kidney Disease. New York: Springer; 2015. pp. 119-36. [DOI: 10.1007/978-1-4939-2395-3_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Davies J, Siebenhandl-Wolff P, Tranquart F, Jones P, Evans P. Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration. Arch Toxicol 2022. [PMID: 34997254 DOI: 10.1007/s00204-021-03189-8] [Reference Citation Analysis]
19 Bak SH, Roh HG, Moon WJ, Choi JW, An HS. Appropriate Minimal Dose of Gadobutrol for 3D Time-Resolved MRA of the Supra-Aortic Arteries: Comparison with Conventional Single-Phase High-Resolution 3D Contrast-Enhanced MRA. AJNR Am J Neuroradiol 2017;38:1383-90. [PMID: 28473338 DOI: 10.3174/ajnr.A5176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
20 Arashloo FT, Hanzaei FF, Sedighi B, Amjad G, Younesi L. Efficacy of diffusion-weighted imaging in symptomatic and asymptomatic multiple sclerotic plaques. J Family Med Prim Care 2019;8:2409-13. [PMID: 31463267 DOI: 10.4103/jfmpc.jfmpc_420_19] [Reference Citation Analysis]
21 Sommer G, Bauman G, Koenigkam-Santos M, Draenkow C, Heussel CP, Kauczor HU, Schlemmer HP, Puderbach M. Non-contrast-enhanced preoperative assessment of lung perfusion in patients with non-small-cell lung cancer using Fourier decomposition magnetic resonance imaging. Eur J Radiol. 2013;82:e879-e887. [PMID: 24041434 DOI: 10.1016/j.ejrad.2013.06.030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
22 Xiao J, Liu P, Wang C, Yang G. External field-assisted laser ablation in liquid: An efficient strategy for nanocrystal synthesis and nanostructure assembly. Progress in Materials Science 2017;87:140-220. [DOI: 10.1016/j.pmatsci.2017.02.004] [Cited by in Crossref: 171] [Cited by in F6Publishing: 69] [Article Influence: 34.2] [Reference Citation Analysis]
23 Kong Y, Zhang S, Wang J, Han C, Yu N, Liu Q, Wang W, Xu K. Potential toxicity evaluation and comparison within multiple mice organs after repeat injections of linear versus macrocyclic gadolinium-based contrast agents: A comprehensive and time course study. Toxicol Lett 2021;350:152-61. [PMID: 34311048 DOI: 10.1016/j.toxlet.2021.07.016] [Reference Citation Analysis]
24 Runowska M, Majewski D, Puszczewicz M. Retroperitoneal fibrosis - the state-of-the-art. Reumatologia 2016;54:256-63. [PMID: 27994271 DOI: 10.5114/reum.2016.63667] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
25 Inoue A, Nitta N, Ohta S, Imoto K, Yamasaki M, Ikeda M, Murata K. StatSensor-i point-of-care creatinine analyzer may identify patients at high-risk of contrast-induced nephropathy. Exp Ther Med 2017;13:3503-8. [PMID: 28587433 DOI: 10.3892/etm.2017.4389] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Knutsson L, Seidemo A, Rydhög Scherman A, Markenroth Bloch K, Kalyani RR, Andersen M, Sundgren PC, Wirestam R, Helms G, van Zijl PCM, Xu X. Arterial Input Functions and Tissue Response Curves in Dynamic Glucose-Enhanced (DGE) Imaging: Comparison Between glucoCEST and Blood Glucose Sampling in Humans. Tomography 2018;4:164-71. [PMID: 30588502 DOI: 10.18383/j.tom.2018.00025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
27 Masuda T, Funama Y, Nakaura T, Sato T, Okimoto T, Masuda S, Yamashita Y, Yoshiura T, Noda N, Baba Y, Awai K. Diagnostic performance of computed tomography digital subtraction angiography of the lower extremities during haemodialysis in patients with suspected peripheral artery disease. Radiography (Lond) 2021;27:888-96. [PMID: 33820690 DOI: 10.1016/j.radi.2021.02.007] [Reference Citation Analysis]
28 Rolla GA, Platas-Iglesias C, Botta M, Tei L, Helm L. 1H and 17O NMR relaxometric and computational study on macrocyclic Mn(II) complexes. Inorg Chem 2013;52:3268-79. [PMID: 23437979 DOI: 10.1021/ic302785m] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
29 Mori K, Saida T, Sato F, Uchikawa Y, Konishi T, Ishiguro T, Hiyama T, Hoshiai S, Okamoto Y, Nasu K, Minami M. Endoleak detection after endovascular aneurysm repair using unenhanced MRI with flow suppression technique: Feasibility study in comparison with contrast-enhanced CT. Eur Radiol 2017;27:336-44. [PMID: 27011375 DOI: 10.1007/s00330-016-4315-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
30 De Sarno F, Ponsiglione AM, Russo M, Grimaldi AM, Forte E, Netti PA, Torino E. Water-Mediated Nanostructures for Enhanced MRI: Impact of Water Dynamics on Relaxometric Properties of Gd-DTPA. Theranostics 2019;9:1809-24. [PMID: 31037140 DOI: 10.7150/thno.27313] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
31 Daldrup-Link HE, Theruvath AJ, Rashidi A, Iv M, Majzner RG, Spunt SL, Goodman S, Moseley M. How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol. Pediatr Radiol 2021. [PMID: 34046709 DOI: 10.1007/s00247-021-05098-5] [Reference Citation Analysis]
32 Tse DML, Tapping CR, Patel R, Morgan R, Bratby MJ, Anthony S, Uberoi R. Surveillance After Endovascular Abdominal Aortic Aneurysm Repair. Cardiovasc Intervent Radiol 2014;37:875-88. [DOI: 10.1007/s00270-014-0916-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
33 Halaska MJ, Rob L, Robova H, Cerny M. Treatment of gynecological cancers diagnosed during pregnancy. Future Oncology 2016;12:2265-75. [DOI: 10.2217/fon-2016-0271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Tuna IS, Tatli S. Contrast-enhanced CT and MR imaging of renal vessels. Abdom Imaging 2014;39:875-91. [DOI: 10.1007/s00261-014-0105-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
35 Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI. Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review. Am J Kidney Dis 2021;77:517-28. [PMID: 32861792 DOI: 10.1053/j.ajkd.2020.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Abdoli M, Chakraborty S, MacLean HJ, Freedman MS. The evaluation of MRI diffusion values of active demyelinating lesions in multiple sclerosis. Mult Scler Relat Disord 2016;10:97-102. [PMID: 27919508 DOI: 10.1016/j.msard.2016.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
37 Glutig K, Hahn G, Kuvvetli P, Endrikat J. Safety of gadobutrol: results of a non-interventional study of 3710 patients, including 404 children. Acta Radiol 2019;60:873-9. [PMID: 30253660 DOI: 10.1177/0284185118801151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
38 Martí-bonmatí L, Martí-bonmatí E. Retención de compuestos de gadolinio usados en resonancia magnética: revisión crítica y recomendaciones de las agencias regulatorias. Radiología 2017;59:469-77. [DOI: 10.1016/j.rx.2017.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
39 Li Y, Liu J, Cao Y, Han X, Shao G, Zhou X, Gu J, Liu T, Cui Y, Shi H. Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction. Sci Rep 2021;11:4297. [PMID: 33619345 DOI: 10.1038/s41598-021-83678-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Di Gregorio E, Furlan C, Atlante S, Stefania R, Gianolio E, Aime S. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging: . Investigative Radiology 2020;55:30-7. [DOI: 10.1097/rli.0000000000000608] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
41 Yamamoto T, Fujimoto K, Okada T, Fushimi Y, Stalder AF, Natsuaki Y, Schmidt M, Togashi K. Time-of-Flight Magnetic Resonance Angiography With Sparse Undersampling and Iterative Reconstruction: Comparison With Conventional Parallel Imaging for Accelerated Imaging. Investigative Radiology 2016;51:372-8. [DOI: 10.1097/rli.0000000000000221] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
42 Radbruch A, Weberling LD, Kieslich PJ, Hepp J, Kickingereder P, Wick W, Schlemmer H, Bendszus M. High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol. Investigative Radiology 2015;50:805-10. [DOI: 10.1097/rli.0000000000000227] [Cited by in Crossref: 163] [Cited by in F6Publishing: 63] [Article Influence: 23.3] [Reference Citation Analysis]
43 Carrasco Muñoz S, Calles Blanco C, Marcin J, Fernández Álvarez C, Lafuente Martínez J. Contrastes basados en gadolinio utilizados en resonancia magnética. Radiología 2014;56:21-8. [DOI: 10.1016/j.rx.2014.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
44 Rausch S, Gakis G, Bedke J, Stenzl A. [Elective organ and function preservation in ureter and renal pelvis tumors]. Urologe A 2014;53:1284-94. [PMID: 25148912 DOI: 10.1007/s00120-014-3557-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
45 Năstase F, Radaschin DS, Niculeț E, Stefanescu BI, Nechita A, Miruna D, Baroiu L, Manuela A, Tatu AL. Gadolinium-based contrast agents in neurofibromatosis type 1 (Review). Exp Ther Med 2021;21:530. [PMID: 33815603 DOI: 10.3892/etm.2021.9962] [Reference Citation Analysis]
46 Gheuens E, Daelemans R, Mesens S. Dialysability of Gadoteric Acid in Patients With End-Stage Renal Disease Undergoing Hemodialysis: . Investigative Radiology 2014;49:505-8. [DOI: 10.1097/rli.0000000000000045] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 2.9] [Reference Citation Analysis]
47 Rajan C, Seema J, Chen YW, Chen TC, Lin MH, Lin CH, Hwang DW. A Gadolinium DO3A Amide m-Phenyl Boronic Acid MRI Probe for Targeted Imaging of Sialated Solid Tumors. Biomedicines 2021;9:1459. [PMID: 34680576 DOI: 10.3390/biomedicines9101459] [Reference Citation Analysis]
48 Lim RP, Hecht EM, Desmond PM. Noncontrast Magnetic Resonance Angiography in the Era of Nephrogenic Systemic Fibrosis and Gadolinium Deposition. J Comput Assist Tomogr 2021;45:37-51. [PMID: 32976265 DOI: 10.1097/RCT.0000000000001074] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Franckenberg S, Berger F, Schaerli S, Ampanozi G, Thali M. Fatal anaphylactic reaction to intravenous gadobutrol, a gadolinium-based MRI contrast agent. Radiol Case Rep 2018;13:299-301. [PMID: 29552267 DOI: 10.1016/j.radcr.2017.09.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
50 Yanagisawa F, Amano Y, Tachi M, Inui K, Asai K, Kumita S. Non-contrast-enhanced T1 Mapping of Dilated Cardiomyopathy: Comparison between Native T1 Values and Late Gadolinium Enhancement. Magn Reson Med Sci 2019;18:12-8. [PMID: 29515087 DOI: 10.2463/mrms.mp.2017-0136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
51 Luo H, Zhang T, Gong NJ, Tamir J, Venkata SP, Xu C, Duan Y, Zhou T, Zhou F, Zaharchuk G, Xue J, Liu Y. Deep learning-based methods may minimize GBCA dosage in brain MRI. Eur Radiol 2021;31:6419-28. [PMID: 33735394 DOI: 10.1007/s00330-021-07848-3] [Reference Citation Analysis]
52 Azzouz M, Rømsing J, Thomsen HS. Can a structured questionnaire identify patients with reduced renal function? Eur Radiol 2014;24:780-4. [PMID: 24275804 DOI: 10.1007/s00330-013-3065-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
53 Chang HC, Chen G, Chung HW, Wu PY, Liang L, Juan CJ, Liu YJ, Tse MD, Chan A, Zhang S, Chiu KW. Multi-shot Diffusion-Weighted MRI With Multiplexed Sensitivity Encoding (MUSE) in the Assessment of Active Inflammation in Crohn's Disease. J Magn Reson Imaging 2021. [PMID: 34169600 DOI: 10.1002/jmri.27801] [Reference Citation Analysis]
54 Zähringer C, Potthast S, Tyndall AJ, Bongartz G, Hohmann J. Serum creatinine measurements: evaluation of a questionnaire according to the ESUR guidelines. Acta Radiol 2015;56:628-34. [PMID: 24867223 DOI: 10.1177/0284185114533244] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
55 Sun H, Xin J, Zhou J, Lu Z, Guo Q. Applying Amide Proton Transfer MR Imaging to Hybrid Brain PET/MR: Concordance with Gadolinium Enhancement and Added Value to [18F]FDG PET. Mol Imaging Biol 2018;20:473-81. [PMID: 29063304 DOI: 10.1007/s11307-017-1136-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
56 Bárta J, Hermann P, Kotek J. Coordination Behavior of 1,4-Disubstituted Cyclen Endowed with Phosphonate, Phosphonate Monoethylester, and H-Phosphinate Pendant Arms. Molecules 2019;24:E3324. [PMID: 31547345 DOI: 10.3390/molecules24183324] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
57 Jeong H, Lee K, Kim M, Kim S, Kim M, Kim H. Signal Intensity of Contrast Enhancement according to TE in 3.0T MRI T1 Imaging. Applied Sciences 2018;8:1138. [DOI: 10.3390/app8071138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Endrikat JS, Dohanish S, Balzer T, Breuer JA. Safety of gadoxetate disodium: Results from the clinical phase II-III development program and postmarketing surveillance. J Magn Reson Imaging 2015;42:634-43. [PMID: 25643844 DOI: 10.1002/jmri.24838] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
59 Ödev K, Tunç R, Varol S, Aydemir H, Yılmaz PD, Korkmaz C. Thoracic Complications in Behçet's Disease: Imaging Findings. Can Respir J 2020;2020:4649081. [PMID: 32566055 DOI: 10.1155/2020/4649081] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Semelka RC, Commander CW, Jay M, Burke LM, Ramalho M. Presumed Gadolinium Toxicity in Subjects With Normal Renal Function: A Report of 4 Cases. Invest Radiol 2016;51:661-5. [DOI: 10.1097/rli.0000000000000318] [Cited by in Crossref: 52] [Cited by in F6Publishing: 16] [Article Influence: 8.7] [Reference Citation Analysis]
61 Khant ZA, Hirai T, Kadota Y, Masuda R, Yano T, Azuma M, Suzuki Y, Tashiro K. T1 Shortening in the Cerebral Cortex after Multiple Administrations of Gadolinium-based Contrast Agents. Magn Reson Med Sci 2017;16:84-6. [PMID: 27725576 DOI: 10.2463/mrms.mp.2016-0054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
62 Nagaraja V, Gulati R, Alkhouli MA, Eleid MF, Williamson EE, Rihal CS. First transcatheter aortic valve replacement with gadobutrol in a patient with severe contrast allergy. Cardiovascular Revascularization Medicine 2022. [DOI: 10.1016/j.carrev.2022.02.021] [Reference Citation Analysis]
63 Mayr A, Klug G, Reinstadler SJ, Feistritzer HJ, Reindl M, Kremser C, Kranewitter C, Bonaros N, Friedrich G, Feuchtner G, Metzler B. Is MRI equivalent to CT in the guidance of TAVR? A pilot study. Eur Radiol 2018;28:4625-34. [PMID: 29736853 DOI: 10.1007/s00330-018-5386-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
64 Schutter R, Lantinga VA, Borra RJH, Moers C. MRI for diagnosis of post-renal transplant complications: current state-of-the-art and future perspectives. MAGMA 2020;33:49-61. [PMID: 31879853 DOI: 10.1007/s10334-019-00813-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Caschera L, Lazzara A, Piergallini L, Ricci D, Tuscano B, Vanzulli A. Contrast agents in diagnostic imaging: Present and future. Pharmacol Res 2016;110:65-75. [PMID: 27168225 DOI: 10.1016/j.phrs.2016.04.023] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 8.2] [Reference Citation Analysis]
66 van Hamersvelt RW, Willemink MJ, de Jong PA, Milles J, Vlassenbroek A, Schilham AMR, Leiner T. Feasibility and accuracy of dual-layer spectral detector computed tomography for quantification of gadolinium: a phantom study. Eur Radiol 2017;27:3677-86. [PMID: 28124106 DOI: 10.1007/s00330-017-4737-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
67 Xiao J, Tian XM, Yang C, Liu P, Luo NQ, Liang Y, Li HB, Chen DH, Wang CX, Li L, Yang GW. Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging. Sci Rep 2013;3:3424. [PMID: 24305731 DOI: 10.1038/srep03424] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 6.7] [Reference Citation Analysis]
68 Eikefjord E, Andersen E, Hodneland E, Hanson EA, Sourbron S, Svarstad E, Lundervold A, Rørvik JT. Dynamic contrast-enhanced MRI measurement of renal function in healthy participants. Acta Radiol 2017;58:748-57. [DOI: 10.1177/0284185116666417] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
69 Davenport MS, Khalatbari S, Cohan RH, Dillman JR, Myles JD, Ellis JH. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology. 2013;268:719-728. [PMID: 23579046 DOI: 10.1148/radiol.13122276] [Cited by in Crossref: 211] [Cited by in F6Publishing: 165] [Article Influence: 23.4] [Reference Citation Analysis]
70 Masselli G, Weston M, Spencer J. The role of imaging in the diagnosis and management of renal stone disease in pregnancy. Clinical Radiology 2015;70:1462-71. [DOI: 10.1016/j.crad.2015.09.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
71 Rouvière O, Cornelis F, Brunelle S, Roy C, André M, Bellin MF, Boulay I, Eiss D, Girouin N, Grenier N, Hélénon O, Lapray JF, Lefèvre A, Matillon X, Ménager JM, Millet I, Ronze S, Sanzalone T, Tourniaire J, Rocher L, Renard-Penna R; “French Society of Genitourinary Imaging Consensus group”. Imaging protocols for renal multiparametric MRI and MR urography: results of a consensus conference from the French Society of Genitourinary Imaging. Eur Radiol 2020;30:2103-14. [PMID: 31900706 DOI: 10.1007/s00330-019-06530-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
72 Nagura K, Bogdanov A, Chumakova N, Vorobiev AK, Moronaga S, Imai H, Matsuda T, Noda Y, Maeda T, Koizumi S, Sakamoto K, Amano T, Yoshino F, Kato T, Komatsu N, Tamura R. Size-tunable MRI-visible nitroxide-based magnetic mixed micelles: preparation, stability, and theranostic application. Nanotechnology 2019;30:224002. [PMID: 30743248 DOI: 10.1088/1361-6528/ab0627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
73 Reimer P, Vosshenrich R. [Contrast agents in radiology: current agents approved, recommendations, and safety aspects]. Radiologe 2013;53:153-64. [PMID: 23340684 DOI: 10.1007/s00117-012-2429-6] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
74 Tsuchida Y, Takata T, Ikarashi T, Iino N, Kazama JJ, Narita I. Dialysis disequilibrium syndrome induced by neoplastic meningitis in a patient receiving maintenance hemodialysis. BMC Nephrol 2013;14:255. [PMID: 24238645 DOI: 10.1186/1471-2369-14-255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Idée J, Fretellier N, Robic C, Corot C. The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update. Critical Reviews in Toxicology 2014;44:895-913. [DOI: 10.3109/10408444.2014.955568] [Cited by in Crossref: 66] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
76 Hasegawa M, Marshall DA, Gonzalez-Cuyar LF, Hippe DS, Samy S, Maravilla KR. Effect of formalin fixation on measured concentrations of deposited gadolinium in human tissue: an autopsy study. Acta Radiol 2021;:284185121994047. [PMID: 33588575 DOI: 10.1177/0284185121994047] [Reference Citation Analysis]
77 Rovira À, Ruiz-Falcó ML, García-Esparza E, López-Laso E, Macaya A, Málaga I, Vázquez É, Vicente J. Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex. J Neurooncol 2014;118:205-23. [PMID: 24771286 DOI: 10.1007/s11060-014-1429-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
78 Davenport MS, Cohan RH, Ellis JH. Contrast media controversies in 2015: imaging patients with renal impairment or risk of contrast reaction. AJR Am J Roentgenol 2015;204:1174-81. [PMID: 25730301 DOI: 10.2214/AJR.14.14259] [Cited by in Crossref: 63] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
79 Low G, Owen NE, Joubert I, Patterson AJ, Graves MJ, Glaser KJ, Alexander GJ, Lomas DJ. Reliability of magnetic resonance elastography using multislice two-dimensional spin-echo echo-planar imaging (SE-EPI) and three-dimensional inversion reconstruction for assessing renal stiffness. J Magn Reson Imaging. 2015;42:844-850. [PMID: 25537823 DOI: 10.1002/jmri.24826] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
80 Paech D, Radbruch A. Dynamic Glucose-Enhanced MR Imaging. Magn Reson Imaging Clin N Am 2021;29:77-81. [PMID: 33237017 DOI: 10.1016/j.mric.2020.09.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
81 Bhargava R, Hahn G, Hirsch W, Kim MJ, Mentzel HJ, Olsen OE, Stokland E, Triulzi F, Vazquez E. Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practice. Magn Reson Insights 2013;6:95-111. [PMID: 25114547 DOI: 10.4137/MRI.S12561] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
82 Schieda N, Blaichman JI, Costa AF, Glikstein R, Hurrell C, James M, Jabehdar Maralani P, Shabana W, Tang A, Tsampalieros A, van der Pol CB, Hiremath S. Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.Can J Kidney Health Dis. 2018;5:2054358118778573. [PMID: 29977584 DOI: 10.1177/2054358118778573] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
83 Seo N, Park SH, Kim KJ, Kang BK, Lee Y, Yang SK, Ye BD, Park SH, Kim SY, Baek S, Han K, Ha HK. MR Enterography for the Evaluation of Small-Bowel Inflammation in Crohn Disease by Using Diffusion-weighted Imaging without Intravenous Contrast Material: A Prospective Noninferiority Study. Radiology. 2016;278:762-772. [PMID: 26348103 DOI: 10.1148/radiol.2015150809] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 12.0] [Reference Citation Analysis]
84 Braun J, Busse R, Darmon-Kern E, Heine O, Auer J, Meyl T, Maurer M, Hamm B, de Bucourt M. Baseline characteristics, diagnostic efficacy, and peri-examinational safety of IV gadoteric acid MRI in 148,489 patients. Acta Radiol 2020;61:910-20. [PMID: 31739672 DOI: 10.1177/0284185119883390] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 Schueller-weidekamm C, Lodemann K, Grisar J, Schueller G, Weber M, Kainberger F, Platzgummer H. Contrast-enhanced MR Imaging of Hand and Finger Joints in Patients with Early Rheumatoid Arthritis: Do We Really Need a Full Dose of Gadobenate Dimeglumine for Assessing Synovial Enhancement at 3 T? Radiology 2013;268:161-9. [DOI: 10.1148/radiol.13121733] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
86 Feng M, Fan YZ, Ma XJ, Li JX, Yang XG. The gadolinium-based contrast agent Omniscan® promotes in vitro fibroblast survival through in situ precipitation. Metallomics 2015;7:1103-10. [PMID: 25867453 DOI: 10.1039/c5mt00055f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
87 Jonker L, Fallahi F. Patients' oral hydration levels and incidence of immediate to short-term mild side-effects in contrast agent enhanced MRI diagnostics. Radiography 2015;21:e64-7. [DOI: 10.1016/j.radi.2015.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Park SH. DWI at MR Enterography for Evaluating Bowel Inflammation in Crohn Disease. AJR Am J Roentgenol. 2016;207:40-48. [PMID: 26959382 DOI: 10.2214/ajr.15.15862] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
89 Vågberg M, Axelsson M, Birgander R, Burman J, Cananau C, Forslin Y, Granberg T, Gunnarsson M, von Heijne A, Jönsson L, Karrenbauer VD, Larsson EM, Lindqvist T, Lycke J, Lönn L, Mentesidou E, Müller S, Nilsson P, Piehl F, Svenningsson A, Vrethem M, Wikström J. Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society. Acta Neurol Scand 2017;135:17-24. [PMID: 27558404 DOI: 10.1111/ane.12667] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
90 Reiser MF. 25th Anniversary of European Radiology. Eur Radiol 2017;27:1-6. [PMID: 27900524 DOI: 10.1007/s00330-016-4655-1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
91 Jeong Y, Na K. Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis. Biomater Res 2018;22:17. [PMID: 29942642 DOI: 10.1186/s40824-018-0127-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
92 Nadolski GJ, Stavropoulos SW. Contrast alternatives for iodinated contrast allergy and renal dysfunction: options and limitations. J Vasc Surg. 2013;57:593-598. [PMID: 23246079 DOI: 10.1016/j.jvs.2012.10.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
93 Rasper M, Wildgruber M, Settles M, Eckstein H, Zimmermann A, Reeps C, Rummeny EJ, Huber AM. 3D non-contrast-enhanced ECG-gated MR angiography of the lower extremities with dual-source radiofrequency transmission at 3.0 T: Intraindividual comparison with contrast-enhanced MR angiography in PAOD patients. Eur Radiol 2016;26:2871-80. [DOI: 10.1007/s00330-015-4089-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
94 Arifin DR, Kulkarni M, Kadayakkara D, Bulte JWM. Fluorocapsules allow in vivo monitoring of the mechanical stability of encapsulated islet cell transplants. Biomaterials 2019;221:119410. [PMID: 31421313 DOI: 10.1016/j.biomaterials.2019.119410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
95 Maurer MH, Härmä KH, Thoeny H. Diffusion-Weighted Genitourinary Imaging. Urologic Clinics of North America 2018;45:407-25. [DOI: 10.1016/j.ucl.2018.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
96 Xie J, Jiang M, Lin Y, Deng H, Li L. Effect of Alprostadil on the Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of 36 Randomized Controlled Trials. Angiology 2018;70:594-612. [DOI: 10.1177/0003319719825597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
97 Cardoso BDP, Vicente AI, Ward JB, Sebastião PJ, Chávez FV, Barroso S, Carvalho A, Keely SJ, Martinho PN, Calhorda MJ. Fe(III) salEen derived Schiff base complexes as potential contrast agents. Inorganica Chimica Acta 2015;432:258-66. [DOI: 10.1016/j.ica.2015.04.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
98 Anemone A, Consolino L, Longo DL. MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent. Eur Radiol 2017;27:2170-9. [DOI: 10.1007/s00330-016-4552-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
99 Agostini A, Kircher MF, Do R, Borgheresi A, Monti S, Giovagnoni A, Mannelli L. Magnetic Resonance Imaging of the Liver (Including Biliary Contrast Agents) Part 1: Technical Considerations and Contrast Materials. Semin Roentgenol 2016;51:308-16. [PMID: 27743567 DOI: 10.1053/j.ro.2016.05.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
100 Mann RM, Mus RD, van Zelst J, Geppert C, Karssemeijer N, Platel B. A Novel Approach to Contrast-Enhanced Breast Magnetic Resonance Imaging for Screening: High-Resolution Ultrafast Dynamic Imaging. Investigative Radiology 2014;49:579-85. [DOI: 10.1097/rli.0000000000000057] [Cited by in Crossref: 110] [Cited by in F6Publishing: 34] [Article Influence: 13.8] [Reference Citation Analysis]
101 Zubler V, Zanetti M, Dietrich TJ, Espinosa N, Pfirrmann CW, Mamisch-Saupe N. Is there an Added Value of T1-Weighted Contrast-Enhanced Fat-suppressed Spin-Echo MR Sequences Compared to STIR Sequences in MRI of the Foot and Ankle? Eur Radiol 2017;27:3452-9. [PMID: 27999984 DOI: 10.1007/s00330-016-4696-5] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
102 Lim RP, Koktzoglou I. Noncontrast magnetic resonance angiography: concepts and clinical applications. Radiol Clin North Am 2015;53:457-76. [PMID: 25953284 DOI: 10.1016/j.rcl.2014.12.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
103 Daftari Besheli L, Aran S, Shaqdan K, Kay J, Abujudeh H. Current status of nephrogenic systemic fibrosis. Clin Radiol. 2014;69:661-668. [PMID: 24582176 DOI: 10.1016/j.crad.2014.01.003] [Cited by in Crossref: 78] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
104 Buchs JB, Buehler L, Moll S, Ruttimann R, Nastasi A, Kasten J, Morel P, Lazeyras F. DCD pigs' kidneys analyzed by MRI to assess ex vivo their viability. Transplantation 2014;97:148-53. [PMID: 24434482 DOI: 10.1097/01.TP.0000438023.02751.22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
105 Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kähäri V, Kárpáti S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkötter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T. European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol Venereol 2017;31:1581-94. [PMID: 28786499 DOI: 10.1111/jdv.14466] [Cited by in Crossref: 42] [Cited by in F6Publishing: 21] [Article Influence: 8.4] [Reference Citation Analysis]
106 Baik J, Kim SH, Lee Y, Yoon JH. Comparison of T2-weighted imaging, diffusion-weighted imaging and contrast-enhanced T1-weighted MR imaging for evaluating perianal fistulas.Clin Imaging. 2017;44:16-21. [PMID: 28395191 DOI: 10.1016/j.clinimag.2017.03.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
107 Peña Q, Wang A, Zaremba O, Shi Y, Scheeren HW, Metselaar JM, Kiessling F, Pallares RM, Wuttke S, Lammers T. Metallodrugs in cancer nanomedicine. Chem Soc Rev 2022. [PMID: 35262108 DOI: 10.1039/d1cs00468a] [Reference Citation Analysis]
108 Gimpel C, Avni EF, Breysem L, Burgmaier K, Caroli A, Cetiner M, Haffner D, Hartung EA, Franke D, König J, Liebau MC, Mekahli D, Ong ACM, Pape L, Titieni A, Torra R, Winyard PJD, Schaefer F. Imaging of Kidney Cysts and Cystic Kidney Diseases in Children: An International Working Group Consensus Statement. Radiology 2019;290:769-82. [PMID: 30599104 DOI: 10.1148/radiol.2018181243] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 9.3] [Reference Citation Analysis]
109 Pittschieler E, Szomolanyi P, Schmid-Schwap M, Weber M, Egerbacher M, Traxler H, Trattnig S. Delayed gadolinium-enhanced MRI of the fibrocartilage disc of the temporomandibular joint--a feasibility study. Magn Reson Imaging 2014;32:1223-9. [PMID: 25131629 DOI: 10.1016/j.mri.2014.08.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
110 Girometti R, Stocca T, Serena E, Granata A, Bertolotto M. Impact of contrast-enhanced ultrasound in patients with renal function impairment. World J Radiol 2017; 9(1): 10-16 [PMID: 28144402 DOI: 10.4329/wjr.v9.i1.10] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
111 Iturri-Clavero F, Galbarriatu-Gutierrez L, Gonzalez-Uriarte A, Tamayo-Medel G, de Orte K, Martinez-Ruiz A, Castellon-Larios K, Bergese SD. "Low-field" intraoperative MRI: a new scenario, a new adaptation. Clin Radiol 2016;71:1193-8. [PMID: 27524673 DOI: 10.1016/j.crad.2016.07.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
112 Kirchin MA, Lorusso V, Pirovano G. Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis? Br J Radiol 2015;88:20140526. [PMID: 25651409 DOI: 10.1259/bjr.20140526] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
113 Zhang Q, Dai X, Zhang H, Zeng Y, Luo K, Li W. Recent advances in development of nanomedicines for multiple sclerosis diagnosis. Biomed Mater 2021;16:024101. [PMID: 33472182 DOI: 10.1088/1748-605X/abddf4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Stomp W, Krabben A, van der Heijde D, Huizinga TW, Bloem JL, Østergaard M, van der Helm-van Mil AH, Reijnierse M. Aiming for a simpler early arthritis MRI protocol: can Gd contrast administration be eliminated? Eur Radiol 2015;25:1520-7. [PMID: 25636414 DOI: 10.1007/s00330-014-3522-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
115 Schneider GK, Stroeder J, Roditi G, Colosimo C, Armstrong P, Martucci M, Buecker A, Raczeck P. T1 Signal Measurements in Pediatric Brain: Findings after Multiple Exposures to Gadobenate Dimeglumine for Imaging of Nonneurologic Disease. AJNR Am J Neuroradiol 2017;38:1799-806. [PMID: 28642266 DOI: 10.3174/ajnr.A5270] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
116 Dobrynin S, Kutseikin S, Morozov D, Krumkacheva O, Spitsyna A, Gatilov Y, Silnikov V, Angelovski G, Bowman MK, Kirilyuk I, Chubarov A. Human Serum Albumin Labelled with Sterically-Hindered Nitroxides as Potential MRI Contrast Agents. Molecules 2020;25:E1709. [PMID: 32276437 DOI: 10.3390/molecules25071709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
117 Lohrke J, Frisk AL, Frenzel T, Schöckel L, Rosenbruch M, Jost G, Lenhard DC, Sieber MA, Nischwitz V, Küppers A, Pietsch H. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents. Invest Radiol 2017;52:324-33. [PMID: 28323657 DOI: 10.1097/RLI.0000000000000344] [Cited by in Crossref: 105] [Cited by in F6Publishing: 44] [Article Influence: 26.3] [Reference Citation Analysis]
118 Zimny A, Zińska L, Bladowska J, Neska-Matuszewska M, Sąsiadek M. Intracranial lesions with high signal intensity on T1-weighted MR images - review of pathologies. Pol J Radiol 2013;78:36-46. [PMID: 24505222 DOI: 10.12659/PJR.889663] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
119 Cantisani V, Bertolotto M, Weskott HP, Romanini L, Grazhdani H, Passamonti M, Drudi FM, Malpassini F, Isidori A, Meloni FM, Calliada F, D'Ambrosio F. Growing indications for CEUS: The kidney, testis, lymph nodes, thyroid, prostate, and small bowel. Eur J Radiol. 2015;84:1675-1684. [PMID: 26014102 DOI: 10.1016/j.ejrad.2015.05.008] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 9.1] [Reference Citation Analysis]
120 Bhargava R, Noga M. Safety and efficacy of gadobutrol-enhanced MRI in patients aged under 2 years-a single-center, observational study. Magn Reson Insights 2013;6:1-12. [PMID: 25114540 DOI: 10.4137/MRI.S10996] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
121 McDonald RJ, Levine D, Weinreb J, Kanal E, Davenport MS, Ellis JH, Jacobs PM, Lenkinski RE, Maravilla KR, Prince MR, Rowley HA, Tweedle MF, Kressel HY. Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates. Radiology 2018;289:517-34. [PMID: 30204075 DOI: 10.1148/radiol.2018181151] [Cited by in Crossref: 121] [Cited by in F6Publishing: 93] [Article Influence: 30.3] [Reference Citation Analysis]
122 Idée J, Fretellier N, Thurnher M, Bonnemain B, Corot C. Physico-chimie et profil toxicologique d’agents de contraste pour l’imagerie par résonance magnétique, les chélates de gadolinium. Annales Pharmaceutiques Françaises 2015;73:266-76. [DOI: 10.1016/j.pharma.2015.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
123 Weberling LD, Kieslich PJ, Kickingereder P, Wick W, Bendszus M, Schlemmer H, Radbruch A. Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration: . Investigative Radiology 2015;50:743-8. [DOI: 10.1097/rli.0000000000000206] [Cited by in Crossref: 134] [Cited by in F6Publishing: 53] [Article Influence: 19.1] [Reference Citation Analysis]
124 Caserta MP, Sakala M, Shen P, Gorden L, Wile G. Presurgical planning for hepatobiliary malignancies: clinical and imaging considerations. Magn Reson Imaging Clin N Am 2014;22:447-65. [PMID: 25086939 DOI: 10.1016/j.mric.2014.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
125 Cartocci G, Santurro A, La Russa R, Guglielmi G, Frati P, Fineschi V. The Choice of Gadolinium-Based Contrast Agents: A Radiologist’s Responsibility between Pharmaceutical Equivalence and Bioethical Issues. Symmetry 2017;9:287. [DOI: 10.3390/sym9110287] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
126 Dou W, Lin CE, Ding H, Shen Y, Dou C, Qian L, Wen B, Wu B. Chemical exchange saturation transfer magnetic resonance imaging and its main and potential applications in pre-clinical and clinical studies. Quant Imaging Med Surg 2019;9:1747-66. [PMID: 31728316 DOI: 10.21037/qims.2019.10.03] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
127 Forghani R. Adverse Effects of Gadolinium-Based Contrast Agents: Changes in Practice Patterns. Top Magn Reson Imaging 2016;25:163-9. [PMID: 27367314 DOI: 10.1097/RMR.0000000000000095] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
128 Poskaite P, Pamminger M, Kranewitter C, Kremser C, Reindl M, Reiter G, Piccini D, Dumfarth J, Henninger B, Tiller C, Holzknecht M, Reinstadler SJ, Klug G, Metzler B, Mayr A. Self-navigated 3D whole-heart MRA for non-enhanced surveillance of thoracic aortic dilation: A comparison to CTA. Magn Reson Imaging 2021;76:123-30. [PMID: 33309920 DOI: 10.1016/j.mri.2020.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
129 Culty T, Goujon A, Defortescu G, Bessede T, Kleinclauss F, Boissier R, Drouin S, Branchereau J, Doerfler A, Prudhomme T, Matillon X, Verhoest G, Tillou X, Ploussard G, Rozet F, Méjean A, Timsit MO. [Localized Prostate cancer in candidates for renal transplantation and recipients of a kidney transplant: The French Guidelines from CTAFU]. Prog Urol 2021;31:4-17. [PMID: 33423746 DOI: 10.1016/j.purol.2020.04.027] [Reference Citation Analysis]
130 Mckinney AM, Gawande R, Pezeshk P, Truwit CL, Rykken JB. Preliminary experience with intravenous gadoxetate disodium as a craniospinal MR contrast agent. European Journal of Radiology 2015;84:2539-47. [DOI: 10.1016/j.ejrad.2015.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
131 Devreux M, Henoumont C, Dioury F, Stanicki D, Boutry S, Larbanoix L, Ferroud C, Muller RN, Laurent S. Bimodal Probe for Magnetic Resonance Imaging and Photoacoustic Imaging Based on a PCTA-Derived Gadolinium(III) Complex and ZW800-1: Bimodal Probe for Magnetic Resonance Imaging and Photoacoustic Imaging Based on a PCTA-Derived Gadolinium(III) Complex and ZW800-1. Eur J Inorg Chem 2019;2019:3354-65. [DOI: 10.1002/ejic.201900387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
132 Tibussek D, Rademacher C, Caspers J, Turowski B, Schaper J, Antoch G, Klee D. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study. Radiology 2017;285:223-30. [PMID: 28640695 DOI: 10.1148/radiol.2017161151] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 11.4] [Reference Citation Analysis]
133 Pozzi-Mucelli RM, Rinta-Kiikka I, Wünsche K, Laukkarinen J, Labori KJ, Ånonsen K, Verbeke C, Del Chiaro M, Kartalis N. Pancreatic MRI for the surveillance of cystic neoplasms: comparison of a short with a comprehensive imaging protocol. Eur Radiol 2017;27:41-50. [PMID: 27246720 DOI: 10.1007/s00330-016-4377-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
134 Masselli G, Derme M, Laghi F, Framarino-dei-malatesta M, Gualdi G. Evaluating the Acute Abdomen in the Pregnant Patient. Radiologic Clinics of North America 2015;53:1309-25. [DOI: 10.1016/j.rcl.2015.06.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
135 Mann RM, Balleyguier C, Baltzer PA, Bick U, Colin C, Cornford E, Evans A, Fallenberg E, Forrai G, Fuchsjäger MH, Gilbert FJ, Helbich TH, Heywang-Köbrunner SH, Camps-Herrero J, Kuhl CK, Martincich L, Pediconi F, Panizza P, Pina LJ, Pijnappel RM, Pinker-Domenig K, Skaane P, Sardanelli F; European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition. Breast MRI: EUSOBI recommendations for women's information. Eur Radiol 2015;25:3669-78. [PMID: 26002130 DOI: 10.1007/s00330-015-3807-z] [Cited by in Crossref: 182] [Cited by in F6Publishing: 150] [Article Influence: 26.0] [Reference Citation Analysis]
136 Nii M, Ishida M, Dohi K, Tanaka H, Kondo E, Ito M, Sakuma H, Ikeda T. Myocardial tissue characterization and strain analysis in healthy pregnant women using cardiovascular magnetic resonance native T1 mapping and feature tracking technique. J Cardiovasc Magn Reson 2018;20:52. [PMID: 30068369 DOI: 10.1186/s12968-018-0476-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
137 Schubert T, Takes M, Aschwanden M, Klarhoefer M, Haas T, Jacob AL, Liu D, Gutzeit A, Kos S. Non-enhanced, ECG-gated MR angiography of the pedal vasculature: comparison with contrast-enhanced MR angiography and digital subtraction angiography in peripheral arterial occlusive disease. Eur Radiol 2016;26:2705-13. [DOI: 10.1007/s00330-015-4068-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
138 Mancio J, Pashakhanloo F, El-Rewaidy H, Jang J, Joshi G, Csecs I, Ngo L, Rowin E, Manning W, Maron M, Nezafat R. Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2021:jeab056. [PMID: 33779725 DOI: 10.1093/ehjci/jeab056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Evrimler Ş, Ocakoğlu G, Algin O. The efficacy of new oral contrast mixture for computed tomography enterography. Pol J Radiol 2019;84:e403-12. [PMID: 31969958 DOI: 10.5114/pjr.2019.89684] [Reference Citation Analysis]
140 Splendiani A, Perri M, Marsecano C, Vellucci V, Michelini G, Barile A, Di Cesare E. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients. Radiol Med 2018;123:125-34. [PMID: 28952018 DOI: 10.1007/s11547-017-0816-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
141 Raczeck P, Fries P, Massmann A, Minko P, Frenzel F, Woerner T, Buecker A, Schneider GK. Diagnostic Performance of a Lower-dose Contrast-Enhanced 4D Dynamic MR Angiography of the Lower Extremities at 3 T Using Multisegmental Time-Resolved Maximum Intensity Projections. J Magn Reson Imaging 2021;54:763-74. [PMID: 33825259 DOI: 10.1002/jmri.27631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Yi J, Lee YH, Song H, Suh J. Double-inversion recovery with synthetic magnetic resonance: a pilot study for assessing synovitis of the knee joint compared to contrast-enhanced magnetic resonance imaging. Eur Radiol 2019;29:2573-80. [DOI: 10.1007/s00330-018-5800-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
143 Schramm C, Eaton J, Ringe KI, Venkatesh S, Yamamura J, MRI working group of the IPSCSG. Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. Hepatology. 2017;66:1675-1688. [PMID: 28555945 DOI: 10.1002/hep.29293] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 11.4] [Reference Citation Analysis]
144 Choi J, Ha R, Wynn R. Nephrogenic Systemic Fibrosis on Mammography. Current Problems in Diagnostic Radiology 2015;44:517-20. [DOI: 10.1067/j.cpradiol.2015.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
145 Fallenberg E, Bick U, Schreer I. Strukturiertes Mammakarzinom-Früherkennungsprogramm: (Risiko-)Kollektive, Methoden und Untersuchungsintervalle. Gynäkologe 2014;47:746-52. [DOI: 10.1007/s00129-014-3348-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
146 Lauenstein T, Ramirez-Garrido F, Kim YH, Rha SE, Ricke J, Phongkitkarun S, Boettcher J, Gupta RT, Korpraphong P, Tanomkiat W, Furtner J, Liu PS, Henry M, Endrikat J. Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study. Invest Radiol 2015;50:416-22. [PMID: 25756684 DOI: 10.1097/RLI.0000000000000145] [Cited by in Crossref: 39] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
147 Yoo RE, Sohn CH, Kang KM, Yun TJ, Choi SH, Kim JH, Park SW. Evaluation of Gadolinium Retention After Serial Administrations of a Macrocyclic Gadolinium-Based Contrast Agent (Gadobutrol): A Single-Institution Experience With 189 Patients. Invest Radiol 2018;53:20-5. [PMID: 28742734 DOI: 10.1097/RLI.0000000000000404] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
148 Cai X, Zhu Q, Zeng Y, Zeng Q, Chen X, Zhan Y. Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy. Int J Nanomedicine 2019;14:8321-44. [PMID: 31695370 DOI: 10.2147/IJN.S218085] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Article Influence: 12.3] [Reference Citation Analysis]
149 Piersson AD, Gorleku PN. Nephrogenic systemic fibrosis: A survey of the use of gadolinium-based contrast agents in Ghana. Radiography (Lond) 2017;23:e108-13. [PMID: 28965904 DOI: 10.1016/j.radi.2017.04.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
150 Schieda N, Maralani PJ, Hurrell C, Tsampalieros AK, Hiremath S. Updated Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney Disease Issued by the Canadian Association of Radiologists. Can Assoc Radiol J 2019;70:226-32. [DOI: 10.1016/j.carj.2019.04.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
151 Giorgi H, Ammerman J, Briffaux J, Fretellier N, Corot C, Bourrinet P. Non-clinical safety assessment of gadoterate meglumine (Dotarem®) in neonatal and juvenile rats. Regulatory Toxicology and Pharmacology 2015;73:960-70. [DOI: 10.1016/j.yrtph.2015.09.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
152 Savarino E, Chianca V, Bodini G, Albano D, Messina C, Tontini GE, Sconfienza LM. Gadolinium accumulation after contrast-enhanced magnetic resonance imaging: Which implications in patients with Crohn’s disease? Digestive and Liver Disease 2017;49:728-30. [DOI: 10.1016/j.dld.2017.04.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
153 Endrikat J, Dohanish S, Schleyer N, Schwenke S, Agarwal S, Balzer T. 10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016. Invest Radiol 2018;53:541-50. [PMID: 29547493 DOI: 10.1097/RLI.0000000000000462] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 7.7] [Reference Citation Analysis]
154 Zhang LJ, Peng J, Wen J, Schoepf UJ, Varga-szemes A, Griffith LP, Yu YM, Tao SM, Li YJ, Ni XF, Xu J, Shi DH, Lu GM. Non-contrast-enhanced magnetic resonance angiography: a reliable clinical tool for evaluating transplant renal artery stenosis. Eur Radiol 2018;28:4195-204. [DOI: 10.1007/s00330-018-5413-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
155 Takumi K, Fukukura Y, Hakamada H, Ideue J, Kumagae Y, Yoshiura T. Value of diffusion tensor imaging in differentiating malignant from benign parotid gland tumors. European Journal of Radiology 2017;95:249-56. [DOI: 10.1016/j.ejrad.2017.08.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
156 Maki JH, Wilson GJ, Cartright SD, Bastawrous S. Patient-specific timing for bolus-chase peripheral MR angiography: Patient-Specific Timing for Peripheral MRA. J Magn Reson Imaging 2016;43:249-60. [DOI: 10.1002/jmri.24968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
157 Beckett KR, Moriarity AK, Langer JM. Safe Use of Contrast Media: What the Radiologist Needs to Know. RadioGraphics 2015;35:1738-50. [DOI: 10.1148/rg.2015150033] [Cited by in Crossref: 120] [Cited by in F6Publishing: 77] [Article Influence: 17.1] [Reference Citation Analysis]
158 Xu B, Kocyigit D, Betancor J, Tan C, Rodriguez ER, Schoenhagen P, Flamm SD, Rodriguez LL, Svensson LG, Griffin BP. Sinus of Valsalva Aneurysms: A State-of-the-Art Imaging Review. J Am Soc Echocardiogr 2020;33:295-312. [PMID: 32143779 DOI: 10.1016/j.echo.2019.11.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
159 Bulte JWM, Daldrup-Link HE. Clinical Tracking of Cell Transfer and Cell Transplantation: Trials and Tribulations. Radiology 2018;289:604-15. [PMID: 30299232 DOI: 10.1148/radiol.2018180449] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
160 Tsushima Y, Awai K, Shinoda G, Miyoshi H, Chosa M, Sunaya T, Endrikat J. Post-marketing surveillance of gadobutrol for contrast-enhanced magnetic resonance imaging in Japan. Jpn J Radiol 2018;36:676-85. [PMID: 30232584 DOI: 10.1007/s11604-018-0778-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
161 Bertolotto M, Freeman S, Richenberg J, Belfield J, Dogra V, Huang DY, Lotti F, Markiet K, Nikolic O, Ramanathan S, Ramchandani P, Rocher L, Secil M, Sidhu PS, Skrobisz K, Studniarek M, Tsili A, Turgut AT, Pavlica P, Derchi LE; Members of the ESUR-SPIWG WG. Ultrasound evaluation of varicoceles: systematic literature review and rationale of the ESUR-SPIWG Guidelines and Recommendations. J Ultrasound 2020;23:487-507. [PMID: 32720266 DOI: 10.1007/s40477-020-00509-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
162 Tsai LL, Grant AK, Mortele KJ, Kung JW, Smith MP. A Practical Guide to MR Imaging Safety: What Radiologists Need to Know. Radiographics 2015;35:1722-37. [PMID: 26466181 DOI: 10.1148/rg.2015150108] [Cited by in Crossref: 64] [Cited by in F6Publishing: 46] [Article Influence: 10.7] [Reference Citation Analysis]
163 Tacher V, Desgranges P, You K, Ridouani F, Marzelle J, Kobeiter H. Feasibility of Three-Dimensional MR Angiography Image Fusion Guidance for Endovascular Abdominal Aortic Aneurysm Repair. Journal of Vascular and Interventional Radiology 2016;27:188-93. [DOI: 10.1016/j.jvir.2015.08.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
164 Maurer MH, Härmä KH, Thoeny H. Diffusion-Weighted Genitourinary Imaging. Radiol Clin North Am 2017;55:393-411. [PMID: 28126222 DOI: 10.1016/j.rcl.2016.10.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
165 Thrippleton MJ, Backes WH, Sourbron S, Ingrisch M, van Osch MJP, Dichgans M, Fazekas F, Ropele S, Frayne R, van Oostenbrugge RJ, Smith EE, Wardlaw JM. Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations. Alzheimers Dement 2019;15:840-58. [PMID: 31031101 DOI: 10.1016/j.jalz.2019.01.013] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 15.7] [Reference Citation Analysis]
166 Rasschaert M, Weller RO, Schroeder JA, Brochhausen C, Idée JM. Retention of Gadolinium in Brain Parenchyma: Pathways for Speciation, Access, and Distribution. A Critical Review. J Magn Reson Imaging 2020;52:1293-305. [PMID: 32246802 DOI: 10.1002/jmri.27124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
167 Forslin Y, Shams S, Hashim F, Aspelin P, Bergendal G, Martola J, Fredrikson S, Kristoffersen-Wiberg M, Granberg T. Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study. AJNR Am J Neuroradiol 2017;38:1311-6. [PMID: 28495943 DOI: 10.3174/ajnr.A5211] [Cited by in Crossref: 36] [Cited by in F6Publishing: 14] [Article Influence: 7.2] [Reference Citation Analysis]
168 Bhalodiya JM, Palit A, Giblin G, Tiwari MK, Prasad SK, Bhudia SK, Arvanitis TN, Williams MA. Identifying Myocardial Infarction Using Hierarchical Template Matching-Based Myocardial Strain: Algorithm Development and Usability Study. JMIR Med Inform 2021;9:e22164. [PMID: 33565992 DOI: 10.2196/22164] [Reference Citation Analysis]
169 Eckerbom P, Hansell P, Cox E, Buchanan C, Weis J, Palm F, Francis S, Liss P. Multiparametric assessment of renal physiology in healthy volunteers using noninvasive magnetic resonance imaging. Am J Physiol Renal Physiol 2019;316:F693-702. [PMID: 30648907 DOI: 10.1152/ajprenal.00486.2018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
170 Colbert GB, Patel TK, Gaddy A, Lerma E. Disease a month: Update and review of contrast-associated acute kidney injury. Dis Mon 2021;:101272. [PMID: 34304868 DOI: 10.1016/j.disamonth.2021.101272] [Reference Citation Analysis]
171 Riccabona M. Contrast Media Use in Pediatrics: Safety Issues. In: Thomsen HS, Webb JAW, editors. Contrast Media. Berlin: Springer Berlin Heidelberg; 2014. pp. 245-53. [DOI: 10.1007/174_2013_901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
172 Michaely HJ, Aschauer M, Deutschmann H, Bongartz G, Gutberlet M, Woitek R, Ertl-Wagner B, Kucharczyk W, Hammerstingl R, De Cobelli F, Rosenberg M, Balzer T, Endrikat J. Gadobutrol in Renally Impaired Patients: Results of the GRIP Study. Invest Radiol 2017;52:55-60. [PMID: 27529464 DOI: 10.1097/RLI.0000000000000307] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 5.2] [Reference Citation Analysis]
173 Wong LM, Ai QYH, Mo FKF, Poon DMC, King AD. Convolutional neural network in nasopharyngeal carcinoma: how good is automatic delineation for primary tumor on a non-contrast-enhanced fat-suppressed T2-weighted MRI? Jpn J Radiol 2021;39:571-9. [PMID: 33544302 DOI: 10.1007/s11604-021-01092-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
174 Webb JA, Thomsen HS. Gadolinium contrast media during pregnancy and lactation. Acta Radiol 2013;54:599-600. [PMID: 23966544 DOI: 10.1177/0284185113484894] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
175 Granata A, Zanoli L, Insalaco M, Valentino M, Pavlica P, Di Nicolò PP, Scuderi M, Fiorini F, Fatuzzo P, Bertolotto M. Contrast-enhanced ultrasound (CEUS) in nephrology: Has the time come for its widespread use? Clin Exp Nephrol. 2015;19:606-615. [PMID: 25351822 DOI: 10.1007/s10157-014-1040-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
176 Shen Y, Goerner FL, Heverhagen JT, Snyder C, Hu D, Li X, Runge VM. In vitro T2 relaxivities of the Gd-based contrast agents (GBCAs) in human blood at 1.5 and 3 T. Acta Radiol 2019;60:694-701. [PMID: 30205704 DOI: 10.1177/0284185118799538] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
177 Cansu A, Bekircavusoglu S, Oguz S, Bulut E, Fidan S. Can diffusion weighted imaging be used as an alternative to contrast-enhanced imaging on magnetic resonance enterography for the assessment of active inflammation in Crohn disease? Medicine (Baltimore) 2020;99:e19202. [PMID: 32080107 DOI: 10.1097/MD.0000000000019202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
178 Endrikat J, Anzalone N. Gadobutrol in India-A Comprehensive Review of Safety and Efficacy. Magn Reson Insights 2017;10:1178623X17730048. [PMID: 28932122 DOI: 10.1177/1178623X17730048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
179 Galea N, Francone M, Zaccagna F, Ciolina F, Cannata D, Algeri E, Agati L, Catalano C, Carbone I. Ultra low-dose of gadobenate dimeglumine for late gadolinium enhancement (LGE) imaging in acute myocardial infarction: A feasibility study. European Journal of Radiology 2014;83:2151-8. [DOI: 10.1016/j.ejrad.2014.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
180 Tedeschi E, Caranci F, Giordano F, Angelini V, Cocozza S, Brunetti A. Gadolinium retention in the body: what we know and what we can do. Radiol med 2017;122:589-600. [DOI: 10.1007/s11547-017-0757-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
181 Blankholm AD, Ginnerup-pedersen B, Stausbøl-grøn B, Haislund M, Laustsen S, Ringgaard S. Non-contrast enhanced magnetic resonance angiography techniques in candidates for kidney transplantation: A comparative study. Radiography 2013;19:212-7. [DOI: 10.1016/j.radi.2013.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
182 de Albóniga-Chindurza A, Ortega-Quintanilla J, Alcalde-López J, Zapata-Arriaza E, González A. [Intra-arterial gadolinium as an alternative to iodinated contrast agent in thrombectomy]. Neurologia (Engl Ed) 2020;35:681-3. [PMID: 31899011 DOI: 10.1016/j.nrl.2019.10.008] [Reference Citation Analysis]
183 Mavrogeni SI, Schwitter J, Gargani L, Pepe A, Monti L, Allanore Y, Matucci-Cerinic M. Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls". Semin Arthritis Rheum 2017;47:79-85. [PMID: 28522072 DOI: 10.1016/j.semarthrit.2017.03.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
184 Traboulsee A, Simon JH, Stone L, Fisher E, Jones DE, Malhotra A, Newsome SD, Oh J, Reich DS, Richert N, Rammohan K, Khan O, Radue EW, Ford C, Halper J, Li D. Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis. AJNR Am J Neuroradiol 2016;37:394-401. [PMID: 26564433 DOI: 10.3174/ajnr.A4539] [Cited by in Crossref: 188] [Cited by in F6Publishing: 80] [Article Influence: 26.9] [Reference Citation Analysis]
185 Zhang Y, Zhao H, Liu Y, Zeng M, Zhang J, Hao D. Diagnostic Performance of Dynamic Contrast-Enhanced MRI and 18F-FDG PET/CT for Evaluation of Soft Tissue Tumors and Correlation with Pathology Parameters. Acad Radiol 2022:S1076-6332(22)00173-8. [PMID: 35396157 DOI: 10.1016/j.acra.2022.03.009] [Reference Citation Analysis]
186 Day GS, Tang-Wai DF. When dementia progresses quickly: a practical approach to the diagnosis and management of rapidly progressive dementia. Neurodegener Dis Manag 2014;4:41-56. [PMID: 24640978 DOI: 10.2217/nmt.13.75] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
187 Sancey L, Kotb S, Truillet C, Appaix F, Marais A, Thomas E, van der Sanden B, Klein JP, Laurent B, Cottier M, Antoine R, Dugourd P, Panczer G, Lux F, Perriat P, Motto-Ros V, Tillement O. Long-term in vivo clearance of gadolinium-based AGuIX nanoparticles and their biocompatibility after systemic injection. ACS Nano 2015;9:2477-88. [PMID: 25703068 DOI: 10.1021/acsnano.5b00552] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 13.3] [Reference Citation Analysis]
188 Glutig K, Bhargava R, Hahn G, Hirsch W, Kunze C, Mentzel HJ, Schaefer JF, Willinek W, Palkowitsch P; GARDIAN study group. Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study. Pediatr Radiol 2016;46:1317-23. [PMID: 27041276 DOI: 10.1007/s00247-016-3599-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
189 Amet S, Launay-Vacher V, Clément O, Frances C, Tricotel A, Stengel B, Gauvrit JY, Grenier N, Reinhardt G, Janus N, Choukroun G, Laville M, Deray G. Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study. Invest Radiol 2014;49:109-15. [PMID: 24169070 DOI: 10.1097/RLI.0000000000000000] [Cited by in Crossref: 53] [Cited by in F6Publishing: 14] [Article Influence: 6.6] [Reference Citation Analysis]
190 Xie H, Lei Y, Wang T, Roper J, Axente M, Bradley JD, Liu T, Yang X. MRI Contrast Enhancement Synthesis Using Cascade Networks with Local Supervision. Med Phys 2022. [PMID: 35229344 DOI: 10.1002/mp.15578] [Reference Citation Analysis]
191 Aghayev A, Gupta S, Dabiri BE, Steigner ML. Vascular imaging in renal donors. Cardiovasc Diagn Ther 2019;9:S116-30. [PMID: 31559158 DOI: 10.21037/cdt.2018.11.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
192 Camera L, Severino R, Faggiano A, Masone S, Mansueto G, Maurea S, Fonti R, Salvatore M. Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma. World J Radiol 2014; 6(10): 840-845 [PMID: 25349667 DOI: 10.4329/wjr.v6.i10.840] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
193 Zanardo M, Sardanelli F, Rainford L, Monti CB, Murray JG, Secchi F, Cradock A. Technique and protocols for cardiothoracic time-resolved contrast-enhanced magnetic resonance angiography sequences: a systematic review. Clin Radiol 2021;76:156.e9-156.e18. [PMID: 33008622 DOI: 10.1016/j.crad.2020.08.028] [Reference Citation Analysis]
194 Mains JR, Donskov F, Pedersen EM, Madsen HH, Rasmussen F. Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic renal cell carcinoma: preliminary results from the Danish Renal Cancer Group Study-1. Invest Radiol 2014;49:601-7. [PMID: 24691140 DOI: 10.1097/RLI.0000000000000058] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
195 Thomsen HS. NSF: Still relevant. J Magn Reson Imaging 2014;40:11-2. [DOI: 10.1002/jmri.24422] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
196 Radbruch A, Richter H, Bücker P, Berlandi J, Schänzer A, Deike-Hofmann K, Kleinschnitz C, Schlemmer HP, Forsting M, Paulus W, Martin LF, van Thriel C, Karst U, Jeibmann A. Is Small Fiber Neuropathy Induced by Gadolinium-Based Contrast Agents? Invest Radiol 2020;55:473-80. [PMID: 32604384 DOI: 10.1097/RLI.0000000000000677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
197 Fries P, Massmann A, Robert P, Corot C, Laschke MW, Schneider G, Buecker A, Müller A. Evaluation of Gadopiclenol and P846, 2 High-Relaxivity Macrocyclic Magnetic Resonance Contrast Agents Without Protein Binding, in a Rodent Model of Hepatic Metastases: Potential Solutions for Improved Enhancement at Ultrahigh Field Strength. Investigative Radiology 2019;54:549-58. [DOI: 10.1097/rli.0000000000000572] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
198 Frankel J, Wilén J, Hansson Mild K. Assessing Exposures to Magnetic Resonance Imaging's Complex Mixture of Magnetic Fields for In Vivo, In Vitro, and Epidemiologic Studies of Health Effects for Staff and Patients. Front Public Health 2018;6:66. [PMID: 29594090 DOI: 10.3389/fpubh.2018.00066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
199 Song X, Walczak P, He X, Yang X, Pearl M, Bulte JWM, Pomper MG, McMahon MT, Janowski M. Salicylic acid analogues as chemical exchange saturation transfer MRI contrast agents for the assessment of brain perfusion territory and blood-brain barrier opening after intra-arterial infusion. J Cereb Blood Flow Metab 2016;36:1186-94. [PMID: 26980755 DOI: 10.1177/0271678X16637882] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
200 Khawaja AZ, Cassidy DB, Al Shakarchi J, McGrogan DG, Inston NG, Jones RG. Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines. Insights Imaging. 2015;6:553-558. [PMID: 26253982 DOI: 10.1007/s13244-015-0420-2] [Cited by in Crossref: 111] [Cited by in F6Publishing: 89] [Article Influence: 15.9] [Reference Citation Analysis]
201 Masselli G, Derchi L, Mchugo J, Rockall A, Vock P, Weston M, Spencer J; ESUR Female Pelvic Imaging Subcommittee. Acute abdominal and pelvic pain in pregnancy: ESUR recommendations. Eur Radiol 2013;23:3485-500. [DOI: 10.1007/s00330-013-2987-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
202 Clevert DA, Sterzik A, Braunagel M, Notohamiprodjo M, Graser A. [Modern imaging of kidney tumors]. Urologe A 2013;52:515-26. [PMID: 23571801 DOI: 10.1007/s00120-012-3098-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
203 Pasquini L, Napolitano A, Visconti E, Longo D, Romano A, Tomà P, Rossi Espagnet MC. Gadolinium-Based Contrast Agent-Related Toxicities. CNS Drugs 2018;32:229-40. [PMID: 29508245 DOI: 10.1007/s40263-018-0500-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 11.3] [Reference Citation Analysis]
204 Cova MA, Stacul F, Quaranta R, Guastalla P, Salvatori G, Banderali G, Fonda C, David V, Gregori M, Zuppa AA, Davanzo R. Radiological contrast media in the breastfeeding woman: a position paper of the Italian Society of Radiology (SIRM), the Italian Society of Paediatrics (SIP), the Italian Society of Neonatology (SIN) and the Task Force on Breastfeeding, Ministry of Health, Italy. Eur Radiol 2014;24:2012-22. [PMID: 24838733 DOI: 10.1007/s00330-014-3198-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
205 Lancelot E. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion. Invest Radiol 2016;51:691-700. [DOI: 10.1097/rli.0000000000000280] [Cited by in Crossref: 62] [Cited by in F6Publishing: 18] [Article Influence: 10.3] [Reference Citation Analysis]
206 Suthiphosuwan S, Kim D, Bharatha A, Oh J. Imaging Markers for Monitoring Disease Activity in Multiple Sclerosis. Curr Treat Options Neurol 2017;19. [DOI: 10.1007/s11940-017-0453-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
207 Wei PY, Shao C, Huan T, Wang HB, Ding ZX, Han ZJ. Diagnostic value of maximum signal intensity on T1-weighted MRI images for differentiating parotid gland tumours along with pathological correlation. Clin Radiol 2021;76:472.e19-25. [PMID: 33731262 DOI: 10.1016/j.crad.2021.02.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Zhang H, Guo SH, Xue ZK, Zhang YR, Wang JR, Che JJ, Liu T, Tao HY, Li GP, Rha SW, Ashraful-Haque SZ, Chen KY. Effect of Calcium Dobesilate in Preventing Contrast-Induced Nephropathy in Patients with Diabetes and Chronic Kidney Disease. Clinics (Sao Paulo) 2021;76:e2942. [PMID: 34669873 DOI: 10.6061/clinics/2021/e2942] [Reference Citation Analysis]
209 Cazzato RL, Garnon J, De Marini P, Auloge P, Koch G, Dalili D, Buy X, Palussiere J, Rao PP, Tricard T, Lang H, Gangi A. Is percutaneous image-guided renal tumour ablation ready for prime time? Br J Radiol 2020;93:20200284. [PMID: 32543890 DOI: 10.1259/bjr.20200284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
210 Zhang H, Tang X, Lv Y, Hu D, Sun J, Wang Y, Zhou J, Peng Y. Amide Proton Transfer-Weighted (APTw) Imaging of Intracranial Infection in Children: Initial Experience and Comparison with Gadolinium-Enhanced T1-Weighted Imaging. Biomed Res Int 2020;2020:6418343. [PMID: 32509865 DOI: 10.1155/2020/6418343] [Reference Citation Analysis]
211 Ye Z, Lu H, Su Q, Xian X, Li L. Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency. Oncotarget 2017;8:102521-30. [PMID: 29254267 DOI: 10.18632/oncotarget.19519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
212 Salerno S, Granata C, Trapenese M, Cannata V, Curione D, Rossi Espagnet MC, Magistrelli A, Tomà P. Is MRI imaging in pediatric age totally safe? A critical reprisal. Radiol Med 2018;123:695-702. [PMID: 29725913 DOI: 10.1007/s11547-018-0896-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
213 Mayerhoefer ME, Archibald SJ, Messiou C, Staudenherz A, Berzaczy D, Schöder H. MRI and PET/MRI in hematologic malignancies. J Magn Reson Imaging 2020;51:1325-35. [PMID: 31260155 DOI: 10.1002/jmri.26848] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
214 Huang L, Yan C, Cui D, Yan Y, Liu X, Lu X, Tan X, Lu X, Xu J, Xu Y, Liu R. Organic Radical Contrast Agents Based on Polyacetylenes Containing 2,2,6,6-Tetramethylpiperidine 1-Oxyl (TEMPO): Targeted Magnetic Resonance (MR)/Optical Bimodal Imaging of Folate Receptor Expressing HeLa Tumors in Vitro and in Vivo a: Organic Radical Contrast Agents For Targeted Molecular Imaging. Macromol Biosci 2015;15:788-98. [DOI: 10.1002/mabi.201400403] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
215 Masselli G, Brunelli R, Monti R, Guida M, Laghi F, Casciani E, Polettini E, Gualdi G. Imaging for acute pelvic pain in pregnancy. Insights Imaging 2014;5:165-81. [PMID: 24535757 DOI: 10.1007/s13244-014-0314-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
216 Puech P, Sufana-Iancu A, Renard B, Lemaitre L. Prostate MRI: can we do without DCE sequences in 2013? Diagn Interv Imaging 2013;94:1299-311. [PMID: 24211261 DOI: 10.1016/j.diii.2013.09.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
217 Lohrke J, Frenzel T, Endrikat J, Alves FC, Grist TM, Law M, Lee JM, Leiner T, Li KC, Nikolaou K, Prince MR, Schild HH, Weinreb JC, Yoshikawa K, Pietsch H. 25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives. Adv Ther 2016;33:1-28. [PMID: 26809251 DOI: 10.1007/s12325-015-0275-4] [Cited by in Crossref: 169] [Cited by in F6Publishing: 131] [Article Influence: 28.2] [Reference Citation Analysis]
218 Sia PI, Curragh D, Patel S, Rajak S, Drivas P, Selva D. Time-resolved three-dimensional technique for dynamic magnetic resonance dacryocystography. Clin Exp Ophthalmol 2019;47:1131-7. [PMID: 31441978 DOI: 10.1111/ceo.13618] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
219 Prince MR, Lee HG, Lee CH, Youn SW, Lee IH, Yoon W, Yang B, Wang H, Wang J, Shih TT, Huang GS, Lirng JF, Palkowitsch P; GARDIAN study group. Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study. Eur Radiol 2017;27:286-95. [PMID: 26960538 DOI: 10.1007/s00330-016-4268-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
220 Kerpel A, Beytelman A, Ofek E, Marom EM. Magnetic Resonance Imaging for the Follow-up of Treated Thymic Epithelial Malignancies. J Thorac Imaging 2019;34:345-50. [PMID: 31464819 DOI: 10.1097/RTI.0000000000000444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Cohen DL, Weinberg I, Uretsky S, Popma JJ, Almonacid A, Hadley G, Cohen SA, Townsend RR. Imaging strategies for safety surveillance after renal artery denervation. Clin Res Cardiol 2021;110:609-19. [PMID: 33646357 DOI: 10.1007/s00392-021-01819-w] [Reference Citation Analysis]
222 Fretellier N, Maazouz M, Luseau A, Baudimont F, Jestin-mayer G, Bourgery S, Rasschaert M, Bruneval P, Factor C, Mecieb F, Idée J, Corot C. Safety profiles of gadolinium chelates in juvenile rats differ according to the risk of dissociation. Reproductive Toxicology 2014;50:171-9. [DOI: 10.1016/j.reprotox.2014.10.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
223 Woitek R, Prayer D, Hojreh A, Helbich T. Radiological staging in pregnant patients with cancer. ESMO Open 2016;1:e000017. [PMID: 27843585 DOI: 10.1136/esmoopen-2015-000017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
224 Vessie EL, Liu DM, Forster B, Kos S, Baxter K, Gagnon J, Klass D. A Practical Guide to Magnetic Resonance Vascular Imaging: Techniques and Applications. Annals of Vascular Surgery 2014;28:1052-61. [DOI: 10.1016/j.avsg.2014.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
225 Kang Y, Choi J, Yoo HJ, Hong SH, Kang HS. Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine Model. Radiology 2017;282:734-42. [DOI: 10.1148/radiol.2016160367] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
226 Blystad I, Håkansson I, Tisell A, Ernerudh J, Smedby Ö, Lundberg P, Larsson EM. Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent. AJNR Am J Neuroradiol 2016;37:94-100. [PMID: 26471751 DOI: 10.3174/ajnr.A4501] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
227 Nagura K, Takemoto Y, Yoshino F, Bogdanov A, Chumakova N, Vorobiev AK, Imai H, Matsuda T, Shimono S, Kato T, Komatsu N, Tamura R. Magnetic Mixed Micelles Composed of a Non-Ionic Surfactant and Nitroxide Radicals Containing a D-Glucosamine Unit: Preparation, Stability, and Biomedical Application. Pharmaceutics 2019;11:E42. [PMID: 30669485 DOI: 10.3390/pharmaceutics11010042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
228 Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review. Clin Rev Allergy Immunol 2017;53:306-36. [PMID: 28712039 DOI: 10.1007/s12016-017-8625-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 44] [Article Influence: 15.8] [Reference Citation Analysis]
229 Rose TA, Choi JW. Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know. The American Journal of Medicine 2015;128:943-9. [DOI: 10.1016/j.amjmed.2015.02.018] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 7.7] [Reference Citation Analysis]
230 Kunze C, Mentzel HJ, Krishnamurthy R, Fleck R, Stenzel M, Bhargava R, Burrowes D, Sutter G, Schultze-Mosgau M, Santiuste M, Hahn G. Pharmacokinetics and Safety of Macrocyclic Gadobutrol in Children Aged Younger Than 2 Years Including Term Newborns in Comparison to Older Populations. Invest Radiol 2016;51:50-7. [PMID: 26340504 DOI: 10.1097/RLI.0000000000000204] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
231 Contti MM, Barbosa MF, Del Carmen Villanueva Mauricio A, Nga HS, Valiatti MF, Takase HM, Bravin AM, de Andrade LGM. Kidney transplantation is associated with reduced myocardial fibrosis. A cardiovascular magnetic resonance study with native T1 mapping. J Cardiovasc Magn Reson 2019;21:21. [PMID: 30917836 DOI: 10.1186/s12968-019-0531-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
232 Kato Y, Ambale-Venkatesh B, Kassai Y, Kasuboski L, Schuijf J, Kapoor K, Caruthers S, Lima JAC. Non-contrast coronary magnetic resonance angiography: current frontiers and future horizons. MAGMA 2020;33:591-612. [PMID: 32242282 DOI: 10.1007/s10334-020-00834-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
233 Mushtaq A, Hou Y, Tian C, Deng T, Xu C, Sun Z, Kong X, Zubair Iqbal M. Facile synthesis of Mn doped TiO2 rhombic nanocomposites for enhanced T1-Magnetic resonance imaging and photodynamic therapy. Materials Research Bulletin 2021;144:111481. [DOI: 10.1016/j.materresbull.2021.111481] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 von Morze C, Engelbach JA, Reed GD, Chen AP, Quirk JD, Blazey T, Mahar R, Malloy CR, Garbow JR, Merritt ME. 15 N-carnitine, a novel endogenous hyperpolarized MRI probe with long signal lifetime. Magn Reson Med 2021;85:1814-20. [PMID: 33179825 DOI: 10.1002/mrm.28578] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
235 Khouri Chalouhi K, Papini GD, Bandirali M, Sconfienza LM, Di Leo G, Sardanelli F. Less is better? Intraindividual and interindividual comparison between 0.075 mmol/kg of gadobenate dimeglumine and 0.1 mmol/kg of gadoterate meglumine for cranial MRI. European Journal of Radiology 2014;83:1245-9. [DOI: 10.1016/j.ejrad.2014.03.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
236 Orlacchio A, Guastoni C, Beretta GD, Cosmai L, Galluzzo M, Gori S, Grassedonio E, Incorvaia L, Marcantoni C, Netti GS, Passamonti M, Porta C, Procopio G, Rizzo M, Roma S, Romanini L, Stacul F, Casinelli A. SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations-consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM). Radiol Med 2022. [PMID: 35303246 DOI: 10.1007/s11547-022-01483-8] [Reference Citation Analysis]
237 Fries P, Müller A, Seidel R, Robert P, Denda G, Menger MD, Schneider G, Buecker A. P03277—A New Approach to Achieve High-Contrast Enhancement: Initial Results of an Experimental Extracellular Gadolinium-Based Magnetic Resonance Contrast Agent. Investigative Radiology 2015;50:835-42. [DOI: 10.1097/rli.0000000000000192] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 2.1] [Reference Citation Analysis]
238 Schieda N, Blaichman JI, Costa AF, Glikstein R, Hurrell C, James M, Jabehdar Maralani P, Shabana W, Tang A, Tsampalieros A, van der Pol C, Hiremath S. Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists. Can Assoc Radiol J 2018;69:136-50. [PMID: 29706252 DOI: 10.1016/j.carj.2017.11.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
239 Endrikat J, Vogtlaender K, Dohanish S, Balzer T, Breuer J. Safety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million Applications. Invest Radiol 2016;51:537-43. [PMID: 26964075 DOI: 10.1097/RLI.0000000000000270] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 4.4] [Reference Citation Analysis]
240 Shiroishi MS, Castellazzi G, Boxerman JL, D'amore F, Essig M, Nguyen TB, Provenzale JM, Enterline DS, Anzalone N, Dörfler A, Rovira À, Wintermark M, Law M. Principles of T 2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging: Principles of T 2 *-Weighted DSC-MRI. J Magn Reson Imaging 2015;41:296-313. [DOI: 10.1002/jmri.24648] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 7.9] [Reference Citation Analysis]
241 Małek ŁA, Werys K, Kłopotowski M, Śpiewak M, Miłosz-Wieczorek B, Mazurkiewicz Ł, Petryka-Mazurkiewicz J, Marczak M, Witkowski A. Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy--comparison with late enhancement quantification. Magn Reson Imaging 2015;33:718-24. [PMID: 25863138 DOI: 10.1016/j.mri.2015.04.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
242 Fraum TJ, Ludwig DR, Bashir MR, Fowler KJ. Gadolinium-based contrast agents: A comprehensive risk assessment. J Magn Reson Imaging 2017;46:338-53. [PMID: 28083913 DOI: 10.1002/jmri.25625] [Cited by in Crossref: 168] [Cited by in F6Publishing: 132] [Article Influence: 33.6] [Reference Citation Analysis]
243 Paech D, Schlemmer HP. Clinical MR Biomarkers. Recent Results Cancer Res 2020;216:719-45. [PMID: 32594403 DOI: 10.1007/978-3-030-42618-7_21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
244 Fananapazir G, Marin D, Suhocki PV, Kim CY, Bashir MR. Vascular Artifact Mimicking Thrombosis on MR Imaging Using Ferumoxytol as a Contrast Agent in Abdominal Vascular Assessment. Journal of Vascular and Interventional Radiology 2014;25:969-76. [DOI: 10.1016/j.jvir.2013.12.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
245 Zhou IY, Catalano OA, Caravan P. Advances in functional and molecular MRI technologies in chronic liver diseases. J Hepatol 2020;73:1241-54. [PMID: 32585160 DOI: 10.1016/j.jhep.2020.06.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
246 Danieli L, Riccitelli GC, Distefano D, Prodi E, Ventura E, Cianfoni A, Kaelin-Lang A, Reinert M, Pravatà E. Brain Tumor-Enhancement Visualization and Morphometric Assessment: A Comparison of MPRAGE, SPACE, and VIBE MRI Techniques. AJNR Am J Neuroradiol 2019;40:1140-8. [PMID: 31221635 DOI: 10.3174/ajnr.A6096] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
247 G H M, G PJ, A A, P G. Detection of Active Plaques in Multiple Sclerosis using 3 and 12 Directional Diffusion-weighted Imaging: Comparison with Gadolinium-enhanced MR Imaging. J Biomed Phys Eng 2020;10:737-44. [PMID: 33364211 DOI: 10.31661/jbpe.v0i0.925] [Reference Citation Analysis]
248 van de Haar HJ, Burgmans S, Hofman PA, Verhey FR, Jansen JF, Backes WH. Blood-brain barrier impairment in dementia: current and future in vivo assessments. Neurosci Biobehav Rev 2015;49:71-81. [PMID: 25524876 DOI: 10.1016/j.neubiorev.2014.11.022] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
249 Do QN, Madhuranthakam AJ, Bendel P, Lenkinski RE. Quantification of Mouse Renal Perfusion Using Arterial Spin Labeled MRI at 1 T. Academic Radiology 2017;24:1079-85. [DOI: 10.1016/j.acra.2017.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
250 Hassan S, Barrett CJ, Crossman DJ. Imaging tools for assessment of myocardial fibrosis in humans: the need for greater detail. Biophys Rev 2020;12:969-87. [PMID: 32705483 DOI: 10.1007/s12551-020-00738-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
251 Monti CB, Codari M, Cozzi A, Alì M, Saggiante L, Sardanelli F, Secchi F. Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction. Eur Radiol Exp 2020;4:21. [PMID: 32242266 DOI: 10.1186/s41747-020-00149-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 He C, Zhou X, Cheng J, Qin L, Dong F, Zhang R, Chen B, Hu H. Diffusion tensor imaging in evaluating testicular injury after unilateral testicular torsion and detorsion in rat model: A preliminary study. Andrologia 2021;53:e14012. [PMID: 33616285 DOI: 10.1111/and.14012] [Reference Citation Analysis]
253 de Albóniga-chindurza A, Ortega-quintanilla J, Alcalde-lópez J, Zapata-arriaza E, González A. Intra-arterial gadolinium as an alternative to iodinated contrast agents in thrombectomy. Neurología (English Edition) 2020;35:681-3. [DOI: 10.1016/j.nrleng.2019.10.001] [Reference Citation Analysis]
254 Epstein E, Blomqvist L. Imaging in endometrial cancer. Best Practice & Research Clinical Obstetrics & Gynaecology 2014;28:721-39. [DOI: 10.1016/j.bpobgyn.2014.04.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
255 Wu MC, Hsu MY, Shie RF, Cheng MH, Chu FI, Lin CY, Fan YP, Chu SY. Non-contrast-enhanced magnetic resonance angiography of facial arteries for pre-operative evaluation of vascularized submental lymph node flaps. BMC Med Imaging 2019;19:68. [PMID: 31420022 DOI: 10.1186/s12880-019-0368-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
256 Thomsen HS. Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Media. In: Thomsen HS, Webb JAW, editors. Contrast Media. Berlin: Springer Berlin Heidelberg; 2014. pp. 207-17. [DOI: 10.1007/174_2013_903] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
257 Kanda T, Oba H, Toyoda K, Kitajima K, Furui S. Brain gadolinium deposition after administration of gadolinium-based contrast agents. Jpn J Radiol 2016;34:3-9. [DOI: 10.1007/s11604-015-0503-5] [Cited by in Crossref: 104] [Cited by in F6Publishing: 92] [Article Influence: 14.9] [Reference Citation Analysis]
258 Xu X, Yadav NN, Knutsson L, Hua J, Kalyani R, Hall E, Laterra J, Blakeley J, Strowd R, Pomper M, Barker P, Chan K, Liu G, McMahon MT, Stevens RD, van Zijl PC. Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients. Tomography 2015;1:105-14. [PMID: 26779568 DOI: 10.18383/j.tom.2015.00175] [Cited by in Crossref: 94] [Cited by in F6Publishing: 101] [Article Influence: 13.4] [Reference Citation Analysis]
259 Geerts B, Leclercq D, Tezenas du Montcel S, Law-ye B, Gerber S, Bernardeschi D, Galanaud D, Dormont D, Pyatigorskaya N. Characterization of Skull Base Lesions Using Pseudo-Continuous Arterial Spin Labeling. Clin Neuroradiol 2019;29:75-86. [DOI: 10.1007/s00062-017-0623-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
260 Frenzel T, Lawaczeck R, Taupitz M, Jost G, Lohrke J, Sieber MA, Pietsch H. Contrast Media for X-ray and Magnetic Resonance Imaging: Development, Current Status and Future Perspectives. Investigative Radiology 2015;50:671-8. [DOI: 10.1097/rli.0000000000000193] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
261 Fries P, Morelli JN, Lux F, Tillement O, Schneider G, Buecker A. The issues and tentative solutions for contrast-enhanced magnetic resonance imaging at ultra-high field strength: Contrast-enhanced ultra-high field MRI. WIREs Nanomed Nanobiotechnol 2014;6:559-73. [DOI: 10.1002/wnan.1291] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
262 Wagstaff PGK, Zondervan PJ, de la Rosette JJMCH, Laguna MP. The Role of Imaging in the Active Surveillance of Small Renal Masses. Curr Urol Rep 2014;15. [DOI: 10.1007/s11934-013-0386-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]